Maxi Value Protection

AIA Maxi Value Protection (MVP) is a protection-led PAYDI — a regular-premium unit-linked life policy whose real selling point is not the investment account but the health and critical-illness rider ecosystem AIA hangs off it. Stripped down, the base contract is an ordinary investment-linked life policy: you pay a regular premium, part buys life cover, part buys units, fees are front-loaded, and the account value is non-guaranteed. What AIA markets hard is the menu of attachable riders: a hospital-and-surgical plan (Premier Hospital & Surgical Extra/Saver) with an annual limit up to Rp20 billion and a booster to Rp50 billion, cashless access across Indonesia, Malaysia, Thailand and Singapore, plus a critical-illness rider (Vital Care) covering up to 169 conditions with a sum assured up to 300%.

In one line, AIA’s pitch is: “One AIA policy gives your family lifetime protection to age 99 and wraps in a near-unlimited regional health card.”

The competitive reality a Legacy Income agent should hold onto: MVP bundles a unit-linked savings wrapper the customer may not need around health cover the customer probably does need. The unit-linked engine carries front-loaded acquisition fees (40% of basic premium in year one), punitive early surrender, and non-guaranteed returns. The health riders are subject to the new POJK 36/2025 co-payment regime — a mandatory 20%-per-claim share from 2026. A cleaner structure for many customers is a dedicated medical plan plus a transparent life policy — which is exactly the alternative an Allianz or TMLI agent can offer.

---

The brochure publishes two named sample illustrations. These are the figures a Legacy Income agent should be able to decode and challenge. No single fully-itemised cash-flow illustration (premium-in vs. account-out year by year with all fees netted) is reproduced in the available brochure text — the RIPLAY that would carry it is image-based — so the agent must produce a field quote for any specific client.

Critical insight for the agent narrative. Both AIA sample cases carry an annual basic premium (Rp22.5M–Rp32M) that is large relative to the Rp200M life sum assured — because most of that premium is funding the attached health and CI riders and the unit-linked account, not the death benefit. And in AIA’s own table, under a flat or negative market the account value drops to zero by year 30, with the policy then sustained only as long as premiums keep coming. That is the structural soft underbelly of every PAYDI and the single most useful number a Legacy Income agent can put on the table.

Read this aloud to yourself: in year one a 40% acquisition charge comes off the basic premium and if the customer surrenders, 95% of the basic-premium account value is clawed back. The first two to three years are economically close to a write-off if the customer walks. This is normal PAYDI behaviour — but it is the exact ground on which a dedicated-medical-plus-transparent-life alternative wins.

The brochure presents two overlapping fee schedules (one with acquisition 40/40/40/20/20/20/5/5/5 and admin Rp35k; another with acquisition 75/65/20/20/15 and admin Rp27.5k/Rp15k). These likely correspond to two premium tiers or product variants. Because the RIPLAY that would disambiguate them is image-based, the agent should treat the 40%-year-one schedule as the headline and verify the applicable tier before quoting.

---

This section is written from AIA’s perspective — who AIA wins with MVP — so a Legacy Income agent can recognise when they are in a real fight and when they are not.

Sweet Spot — where MVP is genuinely hard to beat

• Age 30–45, mass-affluent, healthy, wants one policy that does life + a premium regional health card
• Household income comfortably above Rp 25M/month — can carry a Rp20M–Rp35M annual premium without strain
• Values cashless hospitalisation across Indonesia, Malaysia, Thailand, Singapore — travels or seeks treatment regionally
• Already an AIA or BCA customer — distribution and trust are pre-built; BCA autodebet makes it frictionless
• Attracted to the AIA Vitality wellness-and-cashback loop and wants the highest-ceiling health limits on the market (Rp20B annual / Rp50B booster)
• Wants the convenience of one premium, one statement, one app (MyAIA), and does not mind paying a fee premium for that bundling

Borderline Fit — winnable for either side

• Customers who want the health cover but are indifferent to the investment wrapper — these are squarely contestable: a dedicated medical plan plus a clean life policy can deliver the protection without the unit-linked drag
• Customers who like the brand and limits but are fee-sensitive once the 40% year-one acquisition charge and co-payment are explained
• Younger single professionals — the health rider is attractive, but the life sum assured and savings wrapper are largely wasted on someone with no dependents

Do Not Pitch (where MVP is the wrong product — and the Legacy Income opening)

• Customers whose primary goal is investment return — the fee load and surrender table make MVP a poor savings vehicle; they belong in mutual funds plus term life
• Fee-conscious, lapse-prone, or income-volatile customers — the 95%/90%/70% early surrender schedule is unforgiving
• Customers who want guaranteed outcomes — PAYDI account values are non-guaranteed and can deplete to zero (AIA’s own table shows it)
• Customers who only want catastrophic medical cover at the lowest cost — a standalone medical plan is cheaper and cleaner than buying it wrapped in a unit-linked life policy
• Customers who do not understand, or will resent, the 2026 co-payment (20% per claim) — they will feel mis-sold at the first hospital bill

---

This is the head-to-head a Legacy Income agent needs. Each row states the customer trigger, what AIA leads with, and the Allianz / TMLI counter.

Rule of thumb. If the customer’s first sentence contains “rumah sakit” (hospital), “cashless”, “berobat di luar negeri” (treatment abroad), or “limit tinggi” (high limit), AIA is in a strong position and the Legacy Income agent should pivot to a dedicated-medical-plan comparison rather than attack the health benefit head-on. If the first sentence contains “investasi” (investment), “imbal hasil” (return), “tabungan” (savings), or “dijamin” (guaranteed), MVP is on weak ground and the agent should lead with the fee-drag and non-guaranteed-value argument.

---

Methodology caveat (read first). Quantitative benchmarking of the Indonesian unit-linked (PAYDI) category is limited — parsed RIPLAY coverage sits below the 60% threshold needed for population statistics, so this comparison is qualitative. Worse, MVP’s own economics are partly reconstructed: its RIPLAY is image-based and not text-extractable, so the fee and surrender figures here come from the brochure, which carries two overlapping fee schedules. Fee anchors below are drawn from a clean peer RIPLAY (Sun Solusi Bijak) and the same-run sibling set (AIA Bahagia Bersama, AIA MILA Plus). Treat all cross-product numbers as directional.

Confidence note. Structural and rider-ecosystem claims are drawn directly from the brochure (high confidence on existence, medium on exact terms given the image RIPLAY). All cross-product economic comparisons are analyst assessment against peer anchors, not a parsed head-to-head. Refresh trigger: re-run when (a) AIA’s MVP RIPLAY becomes text-extractable, and (b) PAYDI category PDF coverage exceeds 60%.

---

These are written for a Legacy Income agent positioning against MVP — i.e., to open the conversation, reframe the bundle, and close toward an Allianz/TMLI life policy plus a dedicated medical plan. Keep the tone respectful of AIA; the customer may already admire the brand.

Opening — establish the right frame

“AIA’s health limits are genuinely high — I won’t pretend otherwise. But let me ask a different question first: do you want your health protection and your investment tied together in one product, or do you want each one to do its job cleanly? Because how they’re packaged changes how much you pay and how easily you can change your mind later.”

“Limit kesehatan AIA memang tinggi — saya nggak akan bilang sebaliknya. Tapi izinkan saya tanya hal lain dulu: Bapak/Ibu mau proteksi kesehatan dan investasinya digabung jadi satu produk, atau mau masing-masing bekerja sendiri-sendiri dengan jelas? Karena cara mengemasnya itu menentukan berapa yang Bapak/Ibu bayar dan seberapa gampang nanti kalau mau ubah keputusan.”

The structural value prop — separate the two jobs

“Here’s how I think about it. A unit-linked policy like Maxi Value Protection asks one premium to do three jobs at once — life cover, investing, and your health card — and it charges a large fee up front to set that up: 40% of your basic premium in the first year. If you ever stop in the early years, most of the account value is held back. I’d rather give you a dedicated medical plan that does health cleanly, and a separate life policy where you know exactly what your family receives. Two clear jobs, less fee drag, and you keep your flexibility.”

“Begini cara saya melihatnya. Produk unit-linked seperti Maxi Value Protection minta satu premi mengerjakan tiga hal sekaligus — proteksi jiwa, investasi, dan kartu kesehatan — dan dia ambil biaya besar di depan untuk itu: 40% dari premi dasar di tahun pertama. Kalau berhenti di tahun-tahun awal, sebagian besar nilai akunnya ditahan. Saya lebih suka memberi Bapak/Ibu rencana medis khusus yang menangani kesehatan dengan bersih, plus polis jiwa terpisah di mana Bapak/Ibu tahu persis berapa yang keluarga terima. Dua tugas yang jelas, biaya lebih ringan, dan fleksibilitas tetap di tangan Bapak/Ibu.”

The health-rider angle — respect the strength, reframe the structure

“The Rp20 billion limit sounds limitless, and the regional cashless network is real and useful. But two things to keep in mind. First, from 2026 every health claim carries a co-payment — you pay 20% of each treatment, up to a cap — so it isn’t a blank cheque; that rule applies to my plans too, I’m just making sure you know it. Second, you’re buying that health card wrapped inside an investment policy. If you ever want to keep the health cover but drop the investment, you can’t — they’re welded together. A standalone medical plan lets you keep the protection without being locked to a unit-linked account you may outgrow.”

“Limit Rp20 miliar terdengar tanpa batas, dan jaringan cashless regionalnya memang nyata dan berguna. Tapi ada dua hal yang perlu diingat. Pertama, mulai 2026 setiap klaim kesehatan ada co-payment — Bapak/Ibu menanggung 20% dari tiap perawatan, sampai batas tertentu — jadi bukan cek kosong; aturan ini juga berlaku untuk rencana saya, saya cuma mau Bapak/Ibu tahu. Kedua, kartu kesehatan itu dibeli terbungkus di dalam polis investasi. Kalau nanti mau pertahankan proteksi kesehatannya tapi lepas investasinya, nggak bisa — keduanya menyatu. Rencana medis berdiri sendiri memungkinkan Bapak/Ibu mempertahankan proteksi tanpa terikat pada akun unit-linked yang mungkin sudah tak cocok lagi.”

The close — toward a clean structure

“So my suggestion isn’t ‘don’t protect your health’ — it’s the opposite. Protect it properly with a dedicated medical plan, protect your family with a life policy where the payout is clear, and if you want to invest, let’s do that separately where you can see every rupiah. Same protection, fewer hidden costs, and you stay in control. Can I prepare that side-by-side comparison for you?”

“Jadi saran saya bukan ‘jangan lindungi kesehatan’ — justru sebaliknya. Lindungi dengan benar lewat rencana medis khusus, lindungi keluarga dengan polis jiwa yang payout-nya jelas, dan kalau mau investasi, kita lakukan terpisah di mana setiap rupiah kelihatan. Proteksi yang sama, biaya tersembunyi lebih sedikit, dan kendali tetap di tangan Bapak/Ibu. Boleh saya siapkan perbandingan berdampingannya?”

—

Each objection below is one a Legacy Income agent will hear because the customer is leaning toward MVP. The “Do say” lines position an Allianz/TMLI life policy plus a dedicated medical plan as the cleaner answer. Full EN + ID parity. No attack on AIA’s brand — only on the bundled structure.

1. Fee drag — “But AIA’s product also invests my money, so the fee is worth it.”

Customer “Tapi produk AIA juga menginvestasikan uang saya, jadi biayanya sepadan.”

Don't say “AIA’s fees are a rip-off.” — attacks a brand the customer likes.

Don't say “Biaya AIA itu memeras.”

Do say “It does invest — but look at where your first year goes: 40% of your basic premium is taken as acquisition cost before a single rupiah is invested. Across a fund that charges up to 2.1% a year on top, the drag is real. If investing is a goal, you’ll keep more of your money in a low-cost fund bought separately, with a clean life policy beside it. You’re not losing the investment — you’re removing the toll booth in front of it.”

Do say “Memang berinvestasi — tapi lihat ke mana tahun pertama Bapak/Ibu pergi: 40% dari premi dasar diambil sebagai biaya akuisisi sebelum satu rupiah pun diinvestasikan. Ditambah biaya pengelolaan dana sampai 2,1% per tahun, beban biayanya nyata. Kalau investasi memang tujuannya, Bapak/Ibu akan menyimpan lebih banyak uang lewat reksa dana berbiaya rendah yang dibeli terpisah, dengan polis jiwa yang bersih di sebelahnya. Bukan kehilangan investasinya — hanya menyingkirkan loket tol di depannya.”

—

2. “The health rider already covers me, so why a separate medical plan?”

Customer “Rider kesehatannya sudah meng-cover saya, kenapa harus medis terpisah lagi?”

Don't say “AIA’s health rider is weak.” — it isn’t; you’ll lose credibility.

Don't say “Rider kesehatan AIA itu lemah.”

Do say “AIA’s health rider is strong — that’s exactly my point. You’re getting good health cover, but it’s bolted onto a unit-linked policy. The risk is this: if the investment account runs thin in a flat market — and AIA’s own illustration shows it can fall to zero by year 30 — keeping the riders alive depends on you topping up premiums. A standalone medical plan stands on its own feet; its health protection doesn’t depend on how an investment account performs. I’d rather your hospital cover never be hostage to the market.”

Do say “Rider kesehatan AIA memang kuat — justru itu poin saya. Bapak/Ibu dapat proteksi kesehatan yang bagus, tapi nempel di polis unit-linked. Risikonya begini: kalau akun investasinya menipis saat pasar datar — dan ilustrasi AIA sendiri menunjukkan nilainya bisa jadi nol di tahun ke-30 — menjaga rider tetap aktif bergantung pada Bapak/Ibu menambah premi. Rencana medis berdiri sendiri berdiri di kakinya sendiri; proteksi kesehatannya tidak tergantung performa akun investasi. Saya lebih suka kalau proteksi rumah sakit Bapak/Ibu tidak pernah jadi sandera pasar.”

—

3. Non-guaranteed returns — “The illustration shows my money grows a lot, though.”

Customer “Tapi ilustrasinya menunjukkan uang saya tumbuh banyak.”

Don't say “Those numbers are fake.” — they’re not; they’re projections.

Don't say “Angka-angka itu bohong.”

Do say “Look closely at the same table. The high-growth column looks great — but right next to it is a column where the account hits zero by year 30. Those are not guarantees; they’re scenarios. PAYDI account values are explicitly non-guaranteed — the policy document says the risk is yours. There’s nothing wrong with that if you understand it. But if any part of you wants certainty for your family, a life policy with a guaranteed death benefit gives you a number that doesn’t move with the market.”

Do say “Coba lihat tabel yang sama lebih teliti. Kolom pertumbuhan tinggi terlihat bagus — tapi tepat di sebelahnya ada kolom di mana akunnya jadi nol di tahun ke-30. Itu bukan jaminan; itu skenario. Nilai akun PAYDI secara tegas tidak dijamin — polisnya menyatakan risikonya ada di Bapak/Ibu. Itu sah-sah saja kalau dipahami. Tapi kalau ada bagian dari Bapak/Ibu yang ingin kepastian untuk keluarga, polis jiwa dengan manfaat meninggal yang dijamin memberi angka yang tidak bergerak mengikuti pasar.”

—

4. Tiny early surrender value — “What if I need to stop in a few years?”

Customer “Bagaimana kalau saya perlu berhenti dalam beberapa tahun?”

Don't say “You’ll lose everything.” — overstated and alarming.

Don't say “Bapak/Ibu akan kehilangan semuanya.”

Do say “This is the part agents often gloss over, so I’ll be straight: in MVP, if you surrender in year one, the policy holds back 95% of your basic-premium account value; 90% in year two; 70% in year three. It only reaches zero penalty around year eight. So this product punishes early exit hard. If there’s any chance your income changes in the next few years, that’s a reason to keep your protection in a flexible structure — a medical plan and a life policy you can adjust — rather than locked into a unit-linked account with a steep exit toll.”

Do say “Bagian ini sering dilewati agen, jadi saya akan jujur: di MVP, kalau Bapak/Ibu menyerahkan polis di tahun pertama, 95% dari nilai akun premi dasar ditahan; tahun kedua 90%; tahun ketiga 70%. Penalti baru nol sekitar tahun kedelapan. Jadi produk ini menghukum keluar lebih awal dengan keras. Kalau ada kemungkinan penghasilan Bapak/Ibu berubah beberapa tahun ke depan, itu alasan untuk menjaga proteksi dalam struktur yang fleksibel — rencana medis dan polis jiwa yang bisa disesuaikan — bukan terkunci di akun unit-linked dengan tol keluar yang mahal.”

—

5. Co-payment shock — “Wait, I have to pay part of every hospital bill now?”

Customer “Tunggu, sekarang saya harus ikut bayar sebagian tiap tagihan rumah sakit?”

Don't say “Only AIA does that.” — false; it’s industry-wide.

Don't say “Cuma AIA yang begitu.”

Do say “Yes — and to be fair, this is a regulator rule for the whole industry from 2026, not just AIA. Under POJK 36/2025 you co-pay 20% of each treatment, up to a cap of Rp4 million or Rp25 million depending on the coverage area. I’m telling you because it changes how you should read ‘Rp20 billion limit’ — it’s not zero out-of-pocket. The plans I offer carry the same rule, so the right question isn’t who avoids co-payment — nobody does — it’s which structure gives you the cleanest cover for the premium. Let me show you the comparison.”

Do say “Iya — dan supaya adil, ini aturan regulator untuk seluruh industri mulai 2026, bukan cuma AIA. Berdasarkan POJK 36/2025, Bapak/Ibu ikut menanggung 20% dari tiap perawatan, sampai batas Rp4 juta atau Rp25 juta tergantung area pertanggungan. Saya beri tahu karena ini mengubah cara membaca ‘limit Rp20 miliar’ — bukan berarti nol dari kantong sendiri. Rencana yang saya tawarkan kena aturan yang sama, jadi pertanyaan yang tepat bukan siapa yang bebas co-payment — tidak ada — tapi struktur mana yang memberi proteksi paling bersih untuk preminya. Saya tunjukkan perbandingannya.”

—

These apply both to AIA’s own agents and — by analogy — to any Legacy Income agent who positions against MVP. Cite the regulation by name; do not invent figures.

1. POJK 36/2025 co-payment regime (effective January 2026). The attached health riders (Premier Hospital & Surgical Extra/Saver) are subject to a mandatory co-payment: 20% of each treatment, capped at Rp4 million or Rp25 million depending on coverage area, as stated in the brochure. Any pitch — AIA’s or a competitor’s — that implies “fully covered” or “unlimited free treatment” without disclosing the co-payment is mis-selling under the new conduct rules. Always state the co-payment before the customer signs.

2. PAYDI-specific OJK conduct rules (SEOJK on PAYDI — illustration and suitability). Indonesia’s PAYDI regulation requires a standardised benefit illustration, a customer suitability/risk-profile assessment, and a recorded acknowledgement that the account value is non-guaranteed. Analyst assessment: because MVP’s RIPLAY is image-based, agents must take extra care that the customer receives and signs the full standardised illustration, not a brochure summary, and that the suitability assessment is genuinely completed rather than back-filled.

3. Front-loaded acquisition-cost disclosure. The brochure shows acquisition charges of 40% of basic premium in years one to three under the headline schedule. Failing to walk the customer through this — letting them believe their full premium is invested from day one — is a classic PAYDI mis-selling vector. The first-year fee must be explained in plain language.

4. Surrender-table walk-through. The Biaya Penebusan schedule (95% / 90% / 70% / 50% / 30% in years one to five) means early surrender is severely penalised. Analyst assessment: the customer should be shown the full surrender table and confirm understanding before signing; presenting only later-year values, or skipping the table, is mis-selling. If the customer cannot commit to the medium term, the case should not be written.

5. Mixing life-and-health narratives. MVP bundles a life sum assured, an investment account, and health/CI riders. A customer who believes their “investment” will always be there to pay hospital bills may be shocked when a flat market depletes the account (AIA’s own illustration shows depletion to zero by year 30) and the riders then depend on continued premiums. Analyst assessment: agents must keep the three components distinct in the customer’s mind — life payout, non-guaranteed investment, and rider protection are not interchangeable.

6. Bancassurance servicing-expectation gap. MVP is distributed partly through BCA bancassurance; the brochure states plainly that BCA only refers the product, does not guarantee it, and that it is not covered by the deposit-insurance scheme (LPS). Analyst assessment: customers who assume a bank-sold product carries bank-level guarantees, or who expect ongoing in-branch advice after the sale, face a servicing gap. This expectation must be corrected at point of sale.

7. Image-only RIPLAY data-quality caveat. Analyst assessment: the binding RIPLAY for MVP is image-based and not text-extractable, and the brochure carries two overlapping fee schedules. Any agent — and any internal comparison built on this brief — must verify the exact applicable fee tier, top-up fee, and admin schedule against the official policy document before quoting a specific customer. Do not present brochure-reconstructed economics as confirmed policy terms.

---

---

1. Build a one-page “Bundle vs Clean Structure” comparison handout (EN + ID) contrasting MVP’s all-in-one PAYDI against an Allianz/TMLI life policy plus a dedicated medical plan. Lead with two columns: lifetime fee drag, and “what happens if you stop early.” This is the single highest-leverage asset for agents who meet MVP-leaning prospects.

2. Train the team on the co-payment reframe. Every agent should be able to explain POJK 36/2025 (20% co-pay, Rp4M/Rp25M caps) neutrally — acknowledging it applies to our own medical plans too — and use it to puncture the “Rp20 billion unlimited” impression without misrepresenting it as AIA-specific. Script the line; rehearse it.

3. Prepare a dedicated-medical-plan counter-offer sheet. When the customer’s real driver is the regional cashless health card, agents need an Allianz/TMLI standalone medical product ready to put side by side — matched on cashless regional coverage and annual limit where possible, and winning on “your health cover doesn’t depend on an investment account’s performance.”

4. Surrender-and-depletion field demo. Equip agents to show, on paper, two AIA-published facts: the 95%/90%/70% early surrender clawback, and the account-to-zero-by-year-30 scenario from AIA’s own illustration. These are not Legacy Income claims — they are AIA’s own brochure numbers — which makes them credible and hard to dispute.

5. Verify MVP economics before any formal comparison is published. Because the RIPLAY is image-based and the brochure carries two overlapping fee schedules, assign one analyst to confirm the applicable acquisition/admin/top-up tier (via the AIA RIPLAY PDF or an AIA illustration tool) before this brief’s numbers are used in customer-facing comparison material. Flag any correction back into this file.

---